Aspire-Lakewood Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of November 16, 2026, ASBP trades at $8.18 with a market cap of $11.80M and a P/E ratio of 0.00. ASBP moved -2.26% today. Year to date, ASBP is -95.02%; over the trailing twelve months it is -93.59%. Its 52-week range spans $3.31 to $1,050.36. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aspire Biopharma dismisses auditor Turner Stone, taps CBIZ as replacement: Aspire Biopharma dismissed Turner Stone effective Sept. 24, 2026, and engaged CBIZ CPAs as auditor for fiscal 2026; Turner’s 2025 audit report included a going-concern paragraph.
| Metric | Value |
|---|---|
| Price | $8.18 |
| Market Cap | $11.80M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $1,050.36 |
| 52-Week Low | $3.31 |
| Volume | 8.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.20K |
| Net Income | $-24.48M |
| Gross Margin | 0.00% |
ASBP analyst coverage data. Average price target: $0.00.